01779

44.9806.49%
NS

Nai-Chau Sun

Co-Founder & Executive Director

Dr. Nai-Chau Sun, also known as Bill, is Executive Director of LongBio Pharma (Suzhou) Co. Ltd. from August 15, 2025 and serves Co-Founder and Director from October 26, 2020. Dr. Sun joined the LongBio Pharma (Suzhou) Co. Ltd. on October 26, 2020. He is primarily responsible for the guidance and oversight of the overall research and development strategy of Group. Dr. Sun has extensive experience in biomedical research and development. Prior to founding Group, Dr. Sun was the director of Longxing Pharma (Hangzhou) Co., Ltd. from September 2018 to July 2022. Since August 2001, Dr. Sun has been the chairman of the board of directors of PharMab. PharMab is one of Controlling Shareholders holding approximately 1.14% shareholding in Company as of the Latest Practicable Date. From January 1987 to October 2000, Dr. Sun served as the assistant director of the hybridoma research department of Tanox Inc., a biotech company established in Texas, the United States in 1986. Tanox was listed on the NASDAQ Stock Market in 2000 and was acquired by Genentech, Inc. in 2007. During Dr. Sun’s employment with Tanox, he worked in research and development and was one of the main inventors behind the groundbreaking first generation anti-IgE antibody, Omalizumab (marketed as Xolair®). Before joining the Tanox Inc., Dr. Sun worked in various laboratories of national institute and university in the United States for life science research and development. Dr. Sun obtained a bachelor’s degree of Science in agriculture from the National Taiwan University in Taipei, Taiwan, China in June 1960, a master’s degree in science from the University of Manitoba in Canada in October 1965 and Ph.D. from the Iowa State University in the United States in February 1970. Dr. Sun has become a member of the Honor Society of Phi Kappa Phi of the Iowa State University in December 1970. He has been awarded with the certificate of honor by Zhejiang University in March 2021 for the donation in support of the education development of Zhejiang University.

Positions